The U.S. Securities and Exchange Commission said on Thursday that it charged Cassava Sciences and two of the company's former ...

Researcher Gary Gibson talks at Burke in White Plains about a trial on a new treatment for Alzheimer’s that uses Benfotiamine ...

Results of the human clinical trial will be shared with LifeVantage Consultants at Market Connect in Kansas City, October ...

Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio"), a clinical stage biopharmaceutical company focused on the development of ...

Vivani Medical, Inc. (NASDAQ:VANI) announced that the Bellberry Human Research Ethics Committee has approved, and the ...

Prostate cancer disproportionately affects Black men, leading to higher mortality rates and worse health outcomes compared to ...

Shares of Cassava Sciences fell 10% in post-market trading on Thursday after the U.S. Securities and Exchange Commission ...

This trial also includes an open-label portion for adults with type 1 diabetes up to 15 years since diagnosis. The open-label portion (n=40) is examining the efficacy, safety, and durability of ...

The Securities and Exchange Commission today announced Cassava Sciences, Inc., its founder and former CEO, Remi Barbier, and ...

The NIH called the first phase of the initiative Researching COVID to Enhance Recovery (RECOVER). Its newest project will be ...

Dr. Jeremy Farrar, WHO’s Chief Scientist, emphasized the importance of strengthening country-led R&D and integrating clinical ...